![Ruhi Khan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ruhi Khan
Corporate Officer/Principal chez
CARIBOU BIOSCIENCES, INC.
Fortune : 184 796 $ au 30/06/2026
Profil
Ruhi Khan is currently Director at Edge Animal Health, Inc. since 2024 and Chief Business Officer at Caribou Biosciences, Inc. since 2021.
Former roles include Vice President-Business Development at Acorda Therapeutics, Inc. from 2009 to 2014, and Head-Business Development at both Adastra Pharmaceuticals, Inc. and TempestTx, Inc. from 2019 to 2021.
Education includes an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/02/2026 | 104 998 ( 0,11% ) | 184 796 $ | 30/06/2026 |
Postes actifs de Ruhi Khan
| Sociétés | Poste | Début |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Corporate Officer/Principal | 08/11/2021 |
Edge Animal Health, Inc.
 Edge Animal Health, Inc. BiotechnologyHealth Technology Develops livestock vaccines | Directeur/Membre du Conseil | 01/05/2024 |
Anciens postes connus de Ruhi Khan
| Sociétés | Poste | Fin |
|---|---|---|
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical and commercial development of proprietary drugs | Corporate Officer/Principal | 01/01/2021 |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Corporate Officer/Principal | 01/01/2021 |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2014 |
Formation de Ruhi Khan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical and commercial development of proprietary drugs | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edge Animal Health, Inc.
Edge Animal Health, Inc. BiotechnologyHealth Technology Develops livestock vaccines | Health Technology |
